tag molecular-biology 
Scienmag
SEPTEMBER 9, 2020
Credit: © 2020 KAUST Purifying specific protein molecules from complex mixtures will become easier with a simpler way to detect a molecular “tag” commonly used as a handle to grab the proteins.
The Pharma Data
MARCH 16, 2022
The research scientist at the Max Planck Institute for Medical Research received the award in recognition of his ground-breaking work in establishing various approaches to protein labeling in living cells that have enabled far-reaching advances in chemical and cell biology. Protein labeling (e.g.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
NOVEMBER 9, 2023
Thereafter, there will be two presentations, which are: Jan Terje Andersen, PhD, Professor, Department of Pharmacology, University of Oslo; Research Group Leader, Department of Immunology, Oslo University Hospital, on: ‘Biology-based engineering of versatile antibody and albumin technologies’.
Drug Discovery World
NOVEMBER 13, 2023
Respectively, they will be moderated by previous speaker Noel Pauli, and Joseph Rucker, PhD, Vice President, Research and Development, Integral Molecular. Dorien De Vlieger, PhD, Scientist, Molecular Engineering, Confo Therapeutics, on: ‘ConfoBodies for parallel discovery of GPCR agonistic antibodies’.
XTalks
JANUARY 19, 2024
Omer Nawaz, PhD, Molecular Imaging Director of an emerging biotech, and Michael Lamba, PhD, DABR, Academic Medical Physicist, explored recent breakthroughs in radiotherapy. In a recent webinar by Medpace, Jess Guarnaschelli, MD, Medpace Radiation Oncologist, Dr. Jason T. Anderson, PharmD, PhD, Radiation Clinical Pharmacologist, A.
XTalks
FEBRUARY 11, 2021
Rosalind Franklin is known for her contributions to the field of genetics with her discovery of the molecular structure of DNA. They conducted two experiments, one with radioactive phosphorous to label DNA, and one with radioactive sulfur to tag protein (DNA does not contain sulfur and protein does not contain phosphate groups).
XTalks
AUGUST 17, 2020
To learn more about innovations in the field, Xtalks spoke to Anish Suri, PhD, president and chief scientific officer of Cue Biopharma about the company’s initiatives in the development of immune-based biological compounds for the treatment of cancers and autoimmune diseases. Cell-Based Immunotherapy vs. Immune Biologics.
Expert insights. Personalized for you.
60 
Let's personalize your content